Unlike other growth hormone secretagogues, Ipamorelin does not impact other hormones, such as cortisol or prolactin, and therefore promotes a natural, steady release of GH
Cannabis and GLP-1 medications can both influence symptoms or behaviors that matter during treatment, including eating patterns, nausea, dizziness, sedation, and gastrointestinal comfort
This distinction matters because ongoing provider relationships support medication adjustment, adverse event monitoring, and integration of biomarker dataparticularly important in GLP-1 therapy where dose titration and side-effect management require sustained clinical judgment
The neurological pathways involved in appetite regulation may overlap with circuits involved in mood and emotion, though direct effects on mood remain theoretical and require further study
Regular monitoring of nutritional status and vitamin levels may be warranted
Cleckheaton Pharmacy provides personalised guidance at every stage of treatment, including dose monitoring, symptom management, dietary and hydration advice, and support for nausea or other adverse effects.